Hugel Inc 2021 AR2
The report highlights Hugel's financial and ESG performance for the fiscal year 2021. The company achieved record consolidated revenue of KRW 245.2 billion, driven by its leading botulinum toxin and hyaluronic acid filler products. In terms of sustainability, Hugel promoted board-centered management, implemented a compliance program, and maintained a zero-tolerance policy for workplace harassment. Social initiatives included annual charcoal briquette donations, cosmetics donations through the 'Real Me' campaign, and local community support. Environmental efforts focused on green management, including energy efficiency improvements and solar power utilization at its manufacturing facilities.
Company: Hugel Inc
Sector: Health Care
Country: South Korea
Year: 2021
Type: AR2
Pages: 50
Hugel Inc
Annual Report
The report highlights Hugel's financial and ESG performance for the fiscal year 2021. The company achieved record consolidated revenue of KRW 245.2 billion, driven by its leading botulinum toxin and hyaluronic acid filler products. In terms of sustainability, Hugel promoted board-centered management, implemented a compliance program, and maintained a zero-tolerance policy for workplace harassment. Social initiatives included annual charcoal briquette donations, cosmetics donations through the 'Real Me' campaign, and local community support. Environmental efforts focused on green management, including energy efficiency improvements and solar power utilization at its manufacturing facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees